Abstract
The pharmacokinetics of mezlocillin at two dosages were studied over the course of therapy in 12 patients receiving the drug for the treatment of infections. Patients received an initial dosing regimen of 4 g every 6 h or 5 g every 8 h, which was switched to the alternative regimen after 5 days of treatment. Both drug regimens demonstrated similar pharmacokinetic characteristics, which suggests that the reported dose-dependent elimination of mezlocillin is not an important factor in the clinical use of mezlocillin at the dosages currently used.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergan T. Pharmacokinetics of mezlocillin in healthy volunteers. Antimicrob Agents Chemother. 1978 Dec;14(6):801–806. doi: 10.1128/aac.14.6.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
- Colaizzi P. A., Coniglio A. A., Poynor W. J., Vishniavsky N., Karnes H. T., Polk R. E. Comparative pharmacokinetics of two multiple-dose mezlocillin regimens in normal volunteers. Antimicrob Agents Chemother. 1986 Nov;30(5):675–678. doi: 10.1128/aac.30.5.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Drusano G. L., Forrest A., Fiore D., Auger F., Caplan E. S. Effect of saturable clearance during high-dose mezlocillin therapy. Antimicrob Agents Chemother. 1984 Nov;26(5):686–688. doi: 10.1128/aac.26.5.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gundert-Remy U., Hildebrandt R., Stiehl A., Weber E. Nonlinear mezlocillin kinetics due to dose-dependent metabolism. Clin Pharmacol Ther. 1983 May;33(5):656–662. doi: 10.1038/clpt.1983.89. [DOI] [PubMed] [Google Scholar]
- Mangione A., Boudinot F. D., Schultz R. M., Jusko W. J. Dose-dependent pharmacokinetics of mezlocillin in relation to renal impairment. Antimicrob Agents Chemother. 1982 Mar;21(3):428–435. doi: 10.1128/aac.21.3.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rocci M. L., Jr, Jusko W. J. LAGRAN program for area and moments in pharmacokinetic analysis. Comput Programs Biomed. 1983 Jun;16(3):203–216. doi: 10.1016/0010-468x(83)90082-x. [DOI] [PubMed] [Google Scholar]
